Varenicline for Smoking Cessation in Heavy Drinking Smokers
Status:
Completed
Trial end date:
2010-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether extended pretreatment with varenicline
(Chantix) is more efficacious for smoking cessation than standard pretreatment, how well
varenicline is tolerated in heavy drinking smokers, and whether varenicline reduces alcohol
consumption.
Phase:
Phase 2
Details
Lead Sponsor:
Yale University
Collaborator:
National Institute on Alcohol Abuse and Alcoholism (NIAAA)